Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 2/20 | 0.69 |
| ▸ | HIF1AN | Q9NWT6 | 15/20 | 0.67 |
| ▸ | ACHE | P22303 | 2/20 | 0.60 |
| ▸ | BCHE | P06276 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.56 |
| ▸ | BACE1 | P56817 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19365837 | 0.93 | HIF1AN (0.71) | ODC1HIF1ANACHE | |
| SCHEMBL16865502 | 0.91 | ODC1 (0.84) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16865506 | 0.86 | HIF1AN (0.56) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16694580 | 0.84 | HIF1AN (0.72) | ODC1HIF1ANACHE | |
| SCHEMBL16694579 | 0.84 | HIF1AN (0.72) | ODC1HIF1ANACHE | |
| SCHEMBL31376176 | 0.83 | HIF1AN (0.87) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16694388 | 0.83 | HIF1AN (0.87) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16694389 | 0.83 | HIF1AN (0.87) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL29499925 | 0.82 | ODC1 (1.00) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16865503 | 0.81 | ODC1 (0.55) | ODC1HIF1ANACHEPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9745280-B2 | Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient | SNU R&DB FOUNDATION (KR) | 2017-08-29 | — | — | US | disclosed |
| US-20160340331-A1 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | SNU R&DB FOUNDATION (KR) | 2016-11-24 | — | — | US | disclosed |
| US-20150183797-A1 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | SNU R&DB FOUNDATION (KR) | 2015-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150183797-A1 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | HSP90AB1, HSP90AA1, HIF1AN | ODC1 3423/4885HIF1AN 3/4885ACHE 4868/4885 |
| US-20160340331-A1 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | HSP90AB1, HSP90AA1, HSP90AB2P | ODC1 3782/4885HIF1AN 4/4885ACHE 4870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.